Intravitreal bevacizumab combined with cataract surgery for treatment of exudative macular degeneration.

@article{Jonas2007IntravitrealBC,
  title={Intravitreal bevacizumab combined with cataract surgery for treatment of exudative macular degeneration.},
  author={Jost Bruno Jonas and Ulrich H. M. Spandau and Frank Schlichtenbrede and Teodosio Libondi and Urs Vossmerbaeumer and Stefan von Baltz},
  journal={Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics},
  year={2007},
  volume={23 6},
  pages={599-600}
}
PURPOSE The aim of this study was to report on the combination of an intravitreal injection of bevacizumab and cataract surgery in patients with exudative age-related macular degeneration (AMD). METHODS The interventional case series study included 11 patients (11 eyes) who received an intravitreal injection of 1.5 mg bevacizumab as treatment of exudative AMD (n = 10) or exudative myopic macular degeneration (n = 1), combined with a routine phacoemulsification and posterior chamber lens… CONTINUE READING